Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-20-095636
Filing Date
2020-08-14
Accepted
2020-08-14 17:07:45
Documents
62

Document Format Files

Seq Description Document Type Size
1 424B4 tm2016252-23_424b4.htm 424B4 4892906
2 GRAPHIC lg_curevacfpo-4clr.jpg GRAPHIC 40504
3 GRAPHIC tm2016252d19-fc_programs4c.jpg GRAPHIC 811987
4 GRAPHIC tm2016252d6_riderbofa42820.jpg GRAPHIC 387706
5 GRAPHIC tm2016252d6_fc-transfpo4c.jpg GRAPHIC 512034
6 GRAPHIC tm2016252d6_fc-bodyfpo4c.jpg GRAPHIC 394911
7 GRAPHIC tm2016252d6_fc-rnaooptfpo.jpg GRAPHIC 188317
8 GRAPHIC tm2016252d6_fc-exploongfpo.jpg GRAPHIC 223595
9 GRAPHIC tm2016252d6_lc-halffpo4c.jpg GRAPHIC 496744
10 GRAPHIC tm2016252d6_lc-half2fpo4c.jpg GRAPHIC 148797
11 GRAPHIC tm2016252d6_lc-prodesfpo4c.jpg GRAPHIC 103023
12 GRAPHIC tm2016252d6_fc-prodesfpo4c.jpg GRAPHIC 188729
13 GRAPHIC tm2016252d6_lc-modimfpo4c.jpg GRAPHIC 125271
14 GRAPHIC tm2016252d6_fc-sequence4c.jpg GRAPHIC 167979
15 GRAPHIC tm2016252d6-mrna.jpg GRAPHIC 161398
16 GRAPHIC tm2016252d6_bc-activfpo4c.jpg GRAPHIC 229630
17 GRAPHIC tm2016252d6-successive.jpg GRAPHIC 274950
18 GRAPHIC tm2016252d6_bc-optutrfpo4c.jpg GRAPHIC 117502
19 GRAPHIC tm2016252d6_bc-optorffpo4c.jpg GRAPHIC 160928
20 GRAPHIC tm2016252d6_bc-opt3endfpo4c.jpg GRAPHIC 137075
21 GRAPHIC tm2016252d6-diverse.jpg GRAPHIC 218699
22 GRAPHIC tm2016252d6_sc-vaclpnfpo.jpg GRAPHIC 303470
23 GRAPHIC tm2016252d6_sc-cvcmfpo4c.jpg GRAPHIC 179561
24 GRAPHIC tm2016252d6-cvcm.jpg GRAPHIC 135676
25 GRAPHIC tm2016252d6-production.jpg GRAPHIC 127751
26 GRAPHIC tm2016252d6_ph-buildfpo4c.jpg GRAPHIC 2379805
27 GRAPHIC tm2016252d6_ph-curevac4clr.jpg GRAPHIC 1604041
28 GRAPHIC tm2016252d6-ph_tumor4clr.jpg GRAPHIC 616245
29 GRAPHIC tm2016252d6-tbl_prelim4clr.jpg GRAPHIC 596008
30 GRAPHIC tm2016252d6-fc_cohorts4clr.jpg GRAPHIC 684971
31 GRAPHIC tm2016252d6-tbl_prefer4clr.jpg GRAPHIC 571212
32 GRAPHIC tm2016252d6-bc_prelim4clr.jpg GRAPHIC 2141159
33 GRAPHIC tm2016252d6_ph-melanfpo4c.jpg GRAPHIC 250665
34 GRAPHIC tm2016252d6-ph_lesions4clr.jpg GRAPHIC 279473
35 GRAPHIC tm2016252d6_ph-metafpo4c.jpg GRAPHIC 199853
36 GRAPHIC tm2016252d6_ph-pretrefpo4c.jpg GRAPHIC 130174
37 GRAPHIC tm2016252d6_lc-survfpo4c.jpg GRAPHIC 197463
38 GRAPHIC tm2016252d6_lc-tumorfpo4c.jpg GRAPHIC 152552
39 GRAPHIC tm2016252d6_lc-tumor2fpo4c.jpg GRAPHIC 180661
40 GRAPHIC tm2016252d6_lc-abscofpo4c.jpg GRAPHIC 179721
41 GRAPHIC tm2016252d6_fc-dosek.jpg GRAPHIC 168274
42 GRAPHIC tm2016252-6_riderg42820.jpg GRAPHIC 135900
43 GRAPHIC tm2016252d6-lc_cv72024c.jpg GRAPHIC 483505
44 GRAPHIC tm2016252d6-bc_sars4clr.jpg GRAPHIC 201098
45 GRAPHIC tm2016252d6-bc_induc4clr.jpg GRAPHIC 528620
46 GRAPHIC tm2016252d6-bc_kinet4clr.jpg GRAPHIC 993673
47 GRAPHIC tm2016252-6_riderf42820.jpg GRAPHIC 40922
48 GRAPHIC tm2016252d6_lc-influenfpo4c.jpg GRAPHIC 384598
49 GRAPHIC tm2016252d6_bc-servntfpoo4c.jpg GRAPHIC 317224
50 GRAPHIC tm2016252d6_bc-lungfpoo4c.jpg GRAPHIC 250006
51 GRAPHIC tm2016252d6_fc-liverfpo4c.jpg GRAPHIC 124269
52 GRAPHIC tm2016252d6_sc-25hcfpo4c.jpg GRAPHIC 178879
53 GRAPHIC tm2016252d6_fc-therafpo4c.jpg GRAPHIC 726221
54 GRAPHIC tm2016252d6_lc-aminofpo4c.jpg GRAPHIC 171145
55 GRAPHIC tm2016252d6_ph-ccl4fpo4c.jpg GRAPHIC 551026
56 GRAPHIC tm2016252d6_lc-dfpo4c.jpg GRAPHIC 74949
57 GRAPHIC tm2016252d6_lc-gfpo4c.jpg GRAPHIC 83627
58 GRAPHIC tm2016252d6_lc-rituxfpo4c.jpg GRAPHIC 115145
59 GRAPHIC tm2016252d6_fc-retinafpo4c.jpg GRAPHIC 277281
60 GRAPHIC tm2016252d6_sc-areabuff.jpg GRAPHIC 636142
61 GRAPHIC tm2016252d6_bc-levelsfpo4c.jpg GRAPHIC 185529
62 GRAPHIC lg_curevac-fpo.jpg GRAPHIC 79401
  Complete submission text file 0001104659-20-095636.txt   35691528
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-240076 | Film No.: 201106460
SIC: 2834 Pharmaceutical Preparations